Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) saw unusually-strong trading volume on Friday . Approximately 89,156 shares traded hands during trading, an increase of 23% from the previous session's volume of 72,453 shares.The stock last traded at $116.43 and had previously closed at $123.40.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Benchmark increased their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Wall Street Zen downgraded Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd. Finally, Maxim Group lifted their price target on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th.
View Our Latest Analysis on Nutex Health
Nutex Health Trading Down 7.8%
The company has a 50 day simple moving average of $131.62 and a 200 day simple moving average of $73.95. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The company has a market capitalization of $633.44 million, a PE ratio of -12.25 and a beta of 0.04.
Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $2.71. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The business had revenue of $211.79 million for the quarter, compared to analysts' expectations of $81.09 million.
Insider Activity at Nutex Health
In related news, CFO Jon Christian Bates acquired 1,000 shares of the firm's stock in a transaction dated Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the acquisition, the chief financial officer now owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 38.52% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Nutex Health
Institutional investors have recently modified their holdings of the company. Bank of America Corp DE increased its position in shares of Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after acquiring an additional 2,043 shares during the period. Northern Trust Corp purchased a new stake in Nutex Health in the fourth quarter valued at approximately $200,000. Millennium Management LLC acquired a new position in Nutex Health in the fourth quarter valued at $213,000. World Investment Advisors purchased a new stake in Nutex Health during the 4th quarter valued at approximately $217,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in Nutex Health in the 4th quarter valued at $231,000. 5.32% of the stock is owned by institutional investors and hedge funds.
About Nutex Health
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.